Haematopoietic cell lineage distribution of MPLW515L/K mutations in patients with idiopathic myelofibrosis [4]

British Journal of Haematology

Volumn 137, Issue 4, 2007, Pages 378-379

  Hu, Wen Yang ^a   Zhao, Yan ^a   Ishii, Takefumi ^a   Sozer, Selcuk ^a   Shi, Jun ^a   Zhang, Wei ^a   Bruno, Edward ^a   Hoffman, Ronald ^a   Xu, Mingjiang ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Haematopoietic cell lineage; Idiopathic myelofibrosis; MPLW515L K mutations

Indexed keywords

JANUS KINASE 2;

B LYMPHOCYTE; CELL LINEAGE; CLINICAL ARTICLE; DNA SEQUENCE; GENE MUTATION; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MONOCYTE; MUTATIONAL ANALYSIS; MYELOID METAPLASIA; NATURAL KILLER CELL; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

HUMANS; MUTATION; MYELOFIBROSIS; PLURIPOTENT STEM CELLS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; THROMBOPOIETIN;

EID: 34247473543     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06572.x     Document Type: Letter

References (6)

1. Baxter, E.J., Scott, L.M., Campbell, P.J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G.S., Bench, A.J., Boyd, E.M., Curtin, N., Scott, M.A., Erber, W.N. Green, A.R. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 1054 1061.
2. Ishii, T., Bruno, E., Hoffman, R. Xu, M. (2006) Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera. Blood, 108, 3128 3134.
3. Lasho, T.L., Pardanani, A., McClure, R.F., Mesa, R.A., Levine, R.L., Gilliland, D.G. Tefferi, A. (2006) Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time. British Journal of Haematology, 135, 683 687.
4. Moliterno, A.R., Williams, D.M., Rogers, O. Spivak, J.L. (2006) Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression. Blood, 108, 3913 3915.
5. Pardanani, A.D., Levine, R.L., Lasho, T., Pikman, Y., Mesa, R.A., Wadleigh, M., Steensma, D.P., Elliott, M.A., Wolanskyj, A.P., Hogan, W.J., McClure, R.F., Litzow, M.R., Gilliland, D.G. Tefferi, A. (2006) MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood, 108, 3472 3476.
6. Pikman, Y., Lee, B.H., Mercher, T., McDowell, E., Ebert, B.L., Gozo, M., Cuker, A., Wernig, G., Moore, S., Galinsky, I., DeAngelo, D.J., Clark, J.J., Lee, S.J., Golub, T.R., Wadleigh, M., Gilliland, D.G. Levine, R.L. (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Medicine, 3, e270.